학력

• 2021.03~2023.02 건양대학교대학원 의학과 석사
• 2011.02~2017.02 건양대학교 의학과 학사

경력

• 2024.03~현재 건양대학교병원 혈액종양내과 조교수
• 2022.03~2024.02 서울아산병원 종양내과 임상강사
• 2019.03~2022.02 건양대병원 레지던트
• 2017.03~2018.02 건양대병원 인턴

학회활동

• 대한항암요법연구회 정회원
• 대한종양내과학회 정회원
• 대한암학회 정회원

연구업적

• 2025Accuracy of Gravity-Based Automatic Infusion System for Chemoport Intravenous Infusion [Medical Devices: Evidence and Research]
• 2025Atezolizumab plus bevacizumab is Associated with Favorable Overall Survival Over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma [Oncology]
• 2025Antitumor Activity of Ex Vivo Expanded Tumor Antigen Priming Cytotoxic T Cells Against Malignant Melanoma [Anticancer research]
• 2024Outcomes of systemic treatment according to germline mutational status in patients with metastatic pheochromocytoma and paraganglioma [Clinical Genitourinary Cancer]
• 2024Impact of Etiology on Efficacy Outcomes with Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Retrospective Analysis in Asia-Pacific [Targeted Oncology]
• 2024Factors associated with the efficacy of first-line nivolumab plus chemotherapy in advanced gastric cancer patients with deficient mismatch repair [Gastric Cancer]
• 2024Organ-specific response with first-line atezolizumab-bevacizumab versus lenvatinib for patients with advanced hepatocellular carcinoma [Hepatology international]
• 2024Combination Analysis of PCDHGA12 and CDO1 DNA Methylation in Bronchial Washing Fluid for Lung Cancer Diagnosis [Journal of Korean Medical Science]
• 2023Prognostic significance of 25-hydroxyvitamin D levels in patients with peripheral T-cell lymphoma [Leukemia & Lymphoma]
• 2023Regulating POLR3G by MicroRNA-26a-5p as a promising therapeutic target of lung cancer stemness and chemosensitivity [Noncoding RNA research]
• 2023Neoantigen and MMR Gene Methylation Analysis of BRAF V600e Mutated Non-Small Cell Lung Cancer to Predict the Response of Immunotherapy [Journal of Tumor Science Research]